Bilobalide B hydrolyzed derivatives and application thereof

A technology of ginkgolide and its derivatives, which is applied in the field of medicine, can solve the problem of no 10-O-(dimethylaminoethyl) ginkgolide, etc., and achieve the effect of ensuring safety and effectiveness

Inactive Publication Date: 2011-09-21
秦引林
View PDF1 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, there are no relevant reports about the impurities in t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bilobalide B hydrolyzed derivatives and application thereof
  • Bilobalide B hydrolyzed derivatives and application thereof
  • Bilobalide B hydrolyzed derivatives and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1 Separation and Preparation of Ginkgolide B Hydrolyzed Derivatives

[0019] Take an appropriate amount of 10-O-(dimethylaminoethyl) ginkgolide B methanesulfonate, add methanol to dissolve, separate with TLC, and use CHCl 3 / CH 3 OH (6 / 1) was developed repeatedly to obtain two spots with lower Rf value than the raw material, which were separated on a preparative plate, and the two products obtained were further separated by HPLC preparative column to obtain two compounds (A and B).

Embodiment 2

[0020] Example 2 Synthesis of Ginkgolide B Hydrolyzed Derivatives

[0021] Take about 5.0 g of 10-O-(dimethylaminoethyl) ginkgolide B methanesulfonate, dissolve it in water, add about 1.0 g of sodium carbonate powder, stir at 50°C for 6 hours, filter, and wash the filtrate with ethyl acetate for two Once, the aqueous layer was evaporated to dryness to obtain a white powder, which was separated by column chromatography, CHCl 3 / CH 3 OH (6 / 1) was eluted, and the desired eluent was collected, evaporated to dryness, and dried to obtain two compounds (C and D).

Embodiment 3

[0022] Example 3 Structure Confirmation

[0023] After analysis and identification, the compound C obtained in Example 2 is the same as the compound A obtained in Example 1, and the molecular structure is shown in Formula 1. MS(m / z): 514[M+H] +1 ; 1 H-NMR (CDCl 3 ): δ7.95(d, 1H), 7.62(d, 1H), 7.15(s, 1H), 6.34(s, 1H), 6.12(s, 1H), 5.31(s, 1H), 5.12(s, 1H), 4.54(s, H), 4.38(dt, 1H), 4.07(dd, H), 3.56(dt, H), 2.84(q, H), 2.61(s, H), 2.30(s, H ), 2.18(s,H), 2.13(s,H), 1.88(s,H), 1.73(s,H), 1.10(s,H), 1.04(s,H).

[0024] The compound D obtained in Example 2 is the same as the compound B obtained in Example 1, and its molecular structure is shown in Formula 2. MS(m / z): 514[M+H] +1 ; 1 H-NMR (CDCl 3 ): δ7.88(d, 1H), 7.60(d, 1H), 7.42(d, 1H), 7.12(s, 1H), 6.74(s, 1H), 6.04(s, 1H), 5.27(s, 1H), 5.04(s, 1H), 4.51(s, H), 4.29(dt, 1H), 4.11(dd, H), 3.48(dt, H), 2.71(s, H), 2.26(s, H ), 2.12(s,H), 2.01(s,H), 1.87(s,H), 1.76(s,H), 1.13(s,H), 1.02(s,H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses two bilobalide B hydrolyzed derivatives of which the structural formulae are disclosed in the specification, and also discloses application thereof as impurity reference substances in inspection of related substances of methylsulfonyl 10-O-(dimethylaminoethyl)bilobalide B raw materials and preparations. The methylsulfonyl 10-O-(dimethylaminoethyl)bilobalide B preparations are methylsulfonyl 10-O-(dimethylaminoethyl)bilobalide B water injection, methylsulfonyl 10-O-(dimethylaminoethyl)bilobalide B freeze-dried powder injection, methylsulfonyl 10-O-(dimethylaminoethyl)bilobalide B high-capacity injection and methylsulfonyl 10-O-(dimethylaminoethyl)bilobalide B solid oral liquid. The invention effectively controls the related substances of the methylsulfonyl 10-O-(dimethylaminoethyl)bilobalide B raw materials and preparations, thereby ensuring the safety and effectiveness of the methylsulfonyl 10-O-(dimethylaminoethyl)bilobalide B preparations in clinical use.

Description

technical field [0001] The present invention relates to the use of a class of ginkgolide B hydrolyzed derivatives, especially its application as an impurity reference substance in the inspection of related substances of 10-O-(dimethylaminoethyl) ginkgolide methanesulfonate B and preparations , belonging to the field of medical technology. Background technique [0002] Ginkgolide B (Ginkgolide B, GB) is a diterpene compound with a hexacyclic cage structure extracted from Ginkgo biloba. It is the strongest platelet activating factor (PAF) antagonist found so far. , can stimulate coronary arteries and cerebral arteries, causing their contraction, spasm, resulting in myocardial and brain tissue ischemia. [0003] 10-O-(dimethylaminoethyl) ginkgolide B (structural formula shown in formula III) is a derivative of ginkgolide B, reported by Qin Yinlin and others in the patent (publication number CN 1749257A) the compound [0004] [0005] 10-O-(dimethylaminoethyl) ginkgolide B...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D493/16C07D493/06G01N30/02
Inventor 秦引林
Owner 秦引林
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products